ERAS

Erasca Stock Analysis

AI Rating

Good
  • Quality3/10
  • Growth↓ 4/10
  • Value↑ 5/10
Erasca sales and earnings growth
ERAS Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 36.23%
  • FCF Y/Y↑ 12.69%
Erasca gross and profit margin trends
ERAS Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -51.38%
Erasca net debt vs free cash flow
ERAS Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Erasca stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗